Microfluidic Production of Mangiferin-Loaded Liposomes Enables Gut-Joint Axis Modulation for Early Osteoarthritis Intervention
Related Experiment Video
Updated: Nov 1, 2026

Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs
Published on: January 27, 2023
Yiqun Ren1, Bing Wang2, Bin Ran3
1Biomedical Sciences College (Shandong Medical Biotechnology Research Center), NHC Key Laboratory of Biotechnology Drugs, Shandong First Medical University (Shandong Academy of Medical Sciences), Jinan, Shandong250117, China.
Abstract:
Microfluidic nanomanufacturing provides a controllable and scalable strategy for improving the oral delivery of poorly bioavailable natural compounds. Herein, mangiferin-loaded liposomes (Lip@MG) were fabricated using an in-house-developed continuous microfluidic platform integrated with a high-efficiency micromixer and evaluated as a gut-joint axis-oriented intervention for early knee osteoarthritis (KOA). Compared with the conventional batch method, microfluidic synthesis produced Lip@MG with a more uniform spherical morphology, a clearly defined bilayer structure, and a narrower particle size distribution. By adjusting the flow-rate ratio, Lip@MG with tunable particle sizes from 207.8 to 118.6 nm, reduced polydispersity, and stable negative zeta potentials of up to approximately -35 mV was obtained. In vitro, Lip@MG exhibited favorable cytocompatibility and enhanced chondrocyte viability. Transcriptomic analysis, qRT-PCR, and western blot further indicated that Lip@MG attenuated LPS-induced inflammatory responses in chondrocytes, at least partly by suppressing NF-κB signaling and inhibiting p65 phosphorylation. In an anterior cruciate ligament transection-induced KOA mouse model, oral Lip@MG administration alleviated cartilage degeneration, increased cartilage thickness from 132 to 215 μm, reduced the OARSI score from 2.5 to 1.5, increased subchondral bone mineral density by 27%, and restored colonic barrier integrity, as reflected by a 65% reduction in the colonic histopathological score. Full-length 16S rRNA gene sequencing revealed that Lip@MG reshaped KOA-associated gut dysbiosis by partially restoring the Firmicutes/Bacteroidetes balance and enriching potentially beneficial taxa. These findings demonstrate that microfluidically manufactured Lip@MG is a promising nutritional nanocarrier for microbiota-centered early KOA intervention through coordinated regulation of intestinal homeostasis and joint degeneration.